Contribution of specific ceramides to obesity-associated metabolic diseases

P Hammerschmidt, JC Brüning - Cellular and Molecular Life Sciences, 2022 - Springer
Ceramides are a heterogeneous group of bioactive membrane sphingolipids that play
specialized regulatory roles in cellular metabolism depending on their characteristic fatty …

Lipotoxicity plays a key role in the development of both insulin resistance and muscle atrophy in patients with type 2 diabetes

RCR Meex, EE Blaak, LJC van Loon - Obesity Reviews, 2019 - Wiley Online Library
Insulin resistance and muscle mass loss often coincide in individuals with type 2 diabetes.
Most patients with type 2 diabetes are overweight, and it is well established that obesity and …

Probing the global cellular responses to lipotoxicity caused by saturated fatty acids

M Piccolis, LM Bond, M Kampmann, P Pulimeno… - Molecular cell, 2019 - cell.com
Excessive levels of saturated fatty acids are toxic to cells, although the basis for this
lipotoxicity remains incompletely understood. Here, we analyzed the transcriptome …

The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling

S Fu, SM Watkins, GS Hotamisligil - Cell metabolism, 2012 - cell.com
The endoplasmic reticulum (ER) is a critical site of protein, lipid, and glucose metabolism,
lipoprotein secretion, and calcium homeostasis. Many of the sensing, metabolizing, and …

Lipotoxicity in kidney, heart, and skeletal muscle dysfunction

H Nishi, T Higashihara, R Inagi - Nutrients, 2019 - mdpi.com
Dyslipidemia is a common nutritional and metabolic disorder in patients with chronic kidney
disease. Accumulating evidence supports the hypothesis that prolonged metabolic …

Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease

AK Leamy, RA Egnatchik, JD Young - Progress in lipid research, 2013 - Elsevier
The steady rise in Western obesity rates has been closely linked to significant increases in a
multitude of accompanying health problems including non-alcoholic fatty liver disease …

The role of ceramides in metabolic disorders: when size and localization matters

SM Turpin-Nolan, JC Brüning - Nature Reviews Endocrinology, 2020 - nature.com
Ceramide accumulation is a hallmark in the manifestation of numerous obesity-related
diseases, such as type 2 diabetes mellitus and atherosclerosis. Until the early 2000s …

Cardiac remodeling in obesity

ED Abel, SE Litwin, G Sweeney - Physiological reviews, 2008 - journals.physiology.org
The dramatic increase in the prevalence of obesity and its strong association with
cardiovascular disease have resulted in unprecedented interest in understanding the effects …

Non-alcoholic fatty liver disease: a sign of systemic disease

I Reccia, J Kumar, C Akladios, F Virdis, M Pai, N Habib… - Metabolism, 2017 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) is the most common form of liver disease and
leading cause of cirrhosis in the United States and developed countries. NAFLD is closely …

The effects of obesity on skeletal muscle regeneration

D Akhmedov, R Berdeaux - Frontiers in physiology, 2013 - frontiersin.org
Obesity and metabolic disorders such as type 2 diabetes mellitus are accompanied by
increased lipid deposition in adipose and non-adipose tissues including liver, pancreas …